Core Insights - Serina Therapeutics is advancing SER-252 (POZ-apomorphine) for advanced Parkinson's disease under the 505(b)(2) NDA pathway, with U.S. IND filing planned for Q4 2025 and patient dosing in Australia expected to start in the same quarter [1][4] Company Developments - The FDA's feedback supports the registrational study program for SER-252, indicating that the initial study may be part of a registrational trial program [2][4] - The SER-252-1b study is a randomized, double-blind, placebo-controlled Phase 1b trial designed to evaluate safety, tolerability, and pharmacokinetics of SER-252 versus placebo [5] Product Information - SER-252 is designed to provide continuous dopaminergic stimulation via subcutaneous injection, aiming to reduce motor fluctuations in advanced Parkinson's patients [6] - The POZ platform technology enhances drug delivery by providing greater control in drug loading and release rates, potentially improving the efficacy and safety profile of various therapeutic agents [7][8] Future Plans - Serina plans to initiate U.S. enrollment in Q1 2026 following IND clearance, with data from Australian patients contributing to the overall regulatory review package [4] - The company aims to advance a pipeline of POZ-enabled small molecules that may follow similar regulatory pathways [3]

Core Insights - Comstock Inc. has successfully placed orders and paid deposits totaling $5.1 million for equipment for its solar panel recycling facility, which is set to be the largest in the U.S. with a capacity of 100,000 tons per year, scheduled for delivery in Q4 2025 [1] - The company aims to enhance its balance sheet and operational capabilities through a recent equity offering, which has attracted significant institutional investors [2] - Comstock's billable revenues are projected to increase eightfold in 2025 compared to 2024, reaching over $3.5 million as the company scales its operations [2] Company Objectives and Plans - The company plans to accelerate its market share in solar panel recycling and is awaiting final permits and delivery of its processing system [3] - Comstock aims to reclaim and repurpose every component of end-of-life solar panels into new raw materials [3] - Key objectives for the next 10 months include expanding local storage capacity, completing permitting for the facility by November 2025, and securing additional service agreements with customers [6] Company Overview - Comstock Inc. focuses on innovating and commercializing technologies that support clean energy systems by extracting and converting under-utilized natural resources into reusable metals from end-of-life photovoltaics [4]

Core Points - Battalion Oil Corporation has received confirmation from NYSE American regarding the acceptance of its compliance plan to regain listing standards, with a plan period extending until November 30, 2026 [1][2] - The company was previously notified of noncompliance with NYSE American listing standards and submitted a detailed plan in response, which was accepted on August 19, 2025 [2] - NYSE American staff will monitor the company's progress during the plan period, and failure to comply may lead to delisting procedures [3] Management Comments - The CEO of Battalion Oil Corporation expressed appreciation for the acceptance of the compliance plan and emphasized the company's commitment to restoring compliance and strengthening operations and financial position [4] - The management remains confident in the long-term strategy and aims to deliver value to shareholders, although there is no assurance of success within the plan period [4]

Company Overview - SoundThinking, Inc. (Nasdaq: SSTI) is a leading public safety technology company that provides AI- and data-driven solutions for law enforcement, civic leadership, and security professionals [3] - The company serves over 300 customers and has collaborated with approximately 2,100 agencies to enhance public safety outcomes [3] - SoundThinking's product offerings include ShotSpotter®, CrimeTracer, CaseBuilder, ResourceRouter, SafePointe®, and PlateRanger powered by Rekor® [3] Upcoming Events - SoundThinking will present at the 2025 Annual Gateway Conference on September 4th at 11:00 a.m. Pacific Time [2] - The presentation will be available via live webcast and for replay [2] - Executives from SoundThinking will be available for one-on-one meetings with investors during the conference [2] Company Recognition - SoundThinking has been recognized as a Great Place to Work® company [3]

Core Viewpoint - NI Holdings, Inc. has authorized a repurchase of up to approximately $5 million of its outstanding common stock, in addition to the remaining $1.3 million from a previous authorization, totaling approximately $6.3 million available for repurchase [1][2]. Company Overview - NI Holdings, Inc. is an insurance holding company based in North Dakota, serving as the stock holding company for Nodak Insurance Company, which transitioned from a mutual to a stock organization on March 13, 2017 [4]. Stock Repurchase Details - The timing, number, and value of shares repurchased will be at the discretion of management and will depend on market conditions, trading prices, and legal requirements [2]. - As of July 31, 2025, NI Holdings, Inc. had 20,675,337 shares of common stock outstanding [3].

Core Insights - Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing cell therapies for autoimmune diseases and cancers [3] - The company will participate in the Cantor Global Healthcare Conference 2025 on September 3, 2025, at 9:45 a.m. EDT [1] - Artiva's lead program, AlloNK®, is an allogeneic NK cell therapy currently evaluated in three clinical trials targeting B-cell driven autoimmune diseases [3] Company Overview - Artiva Biotherapeutics was founded in 2019 as a spin-out from GC Cell, gaining exclusive worldwide rights to NK cell manufacturing technology [3] - The company is headquartered in San Diego, California [4] - Artiva's pipeline includes CAR-NK candidates aimed at treating both solid and hematologic cancers [3] Conference Participation - Members of Artiva's management team will be available for investor meetings during the conference [2] - A live webcast of the presentation will be accessible through the "Investors" section on Artiva's website, with a replay available for 90 days post-event [2]

Core Viewpoint - Sportsman's Warehouse Holdings, Inc. will hold its quarterly conference call to discuss the second quarter 2025 financial results on September 4, 2025, at 5:00 p.m. Eastern Time [1]. Group 1 - A live audio webcast of the conference call will be available on the Company's investor relations website [2]. - A replay of the webcast will be accessible within two hours of the call's conclusion through September 11, 2025 [2]. Group 2 - Sportsman's Warehouse is an outdoor specialty retailer catering to both seasoned outdoor veterans and first-time participants, providing gear and exceptional service [3]. - Additional information and press releases about the Company can be found in the Investor Relations section of the Company's website [3]. Group 3 - Investor contact for Sportsman's Warehouse is Riley Timmer, VP of Investor Relations, available at (801) 304-2816 or via email at investors@sportsmans.com [4].

Core Insights - OrthoPediatrics Corp. announced the appointment of Kelly Fischer to its Board of Directors, effective August 8, 2025, alongside the retirement of Terry Schlotterback from the board on the same date [1][2]. Group 1: Board Changes - Kelly Fischer brings extensive financial leadership experience from her role as Senior Vice President and Chief Financial Officer at Cook Medical, a multibillion-dollar medical device company [2]. - Terry Schlotterback has served over fifteen years as a Director and Chairman of the Board, contributing significantly to the company's establishment as a leader in pediatric orthopedics [2]. Group 2: Company Strategy and Vision - Kelly Fischer expressed her commitment to supporting OrthoPediatrics' strategy to increase market share, launch new technologies, and expand the specialty bracing franchise efficiently [3]. - The company aims to help one million children by advancing its offerings in the pediatric orthopedic field [3]. Group 3: Company Overview - Founded in 2006, OrthoPediatrics focuses exclusively on pediatric orthopedics, offering over 80 products across trauma and deformity, scoliosis, and sports medicine categories [4]. - The company's global sales organization distributes its products in the United States and over 70 countries, emphasizing its commitment to improving the lives of children with orthopedic conditions [4].

Core Viewpoint - zSpace, Inc. is set to present at the 2025 Annual Gateway Conference, highlighting its leadership in immersive augmented reality solutions for education [1][5]. Company Participation - zSpace's management will present on September 4 at 11:00 a.m. PT, with the presentation available for live webcast and replay [2]. - Executives from zSpace will be available for one-on-one meetings throughout the conference [2]. Media Engagement - zSpace will participate in a recorded interview with host Katie Perry, aimed at engaging Stocktwits' retail investor audience of over 10 million [3]. Conference Overview - The Gateway Conference connects growth-stage companies with investors, analysts, and partners, featuring presentations and meetings with over 75 public and private companies [5][6]. Company Background - zSpace, Inc. specializes in augmented reality and AI-powered immersive learning experiences, serving K-12 and post-secondary education sectors [8]. - The company is trusted by over 3,500 educational institutions and holds over 70 patents in immersive technology [8].

ALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Morgan Stanley Healthcare Conference in New York City. RxSight’s management is scheduled to present on Monday, September 8, 2025, at 7:45 a.m. Pacific Time / 10:45 a.m. Eastern Time. A live and archived webcast of the presentation will be avai ...